Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D | O15399 | 2/20 | 0.50 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.50 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.50 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.50 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.50 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.50 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.50 |
| ▸ | PNMT | P11086 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 6/20 | 0.41 |
| ▸ | MAOA | P21397 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9467531 | 0.87 | LMNA (0.48) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL8747758 | 0.85 | PNMT (0.56) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL9147001 | 0.82 | GRIN2D (0.55) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL23071388 | 0.79 | GRIN2D (0.33) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL9467542 | 0.78 | KDM1A (0.36) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL6939188 | 0.78 | GRIN2D (0.57) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL181479 | 0.78 | GRIN2D (0.62) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL21409729 | 0.77 | ALDH1A1 (0.67) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL3049401 | 0.77 | ESR2 (0.52) | — | |
| SCHEMBL26006728 | 0.77 | MEN1 (0.47) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9890244-B2 | Thermally decomposable polymer compositions incorporating thermally activated base generators | SUMITOMO BAKELITE CO., LTD. (JP) | 2018-02-13 | — | — | US | claimed |
| US-20150337081-A1 | THERMALLY DECOMPOSABLE POLYMER COMPOSITIONS INCORPORATING THERMALLY ACTIVATED BASE GENERATORS | PROMERUS, LLC (US) | 2015-11-26 | — | — | US | claimed |
| US-9115300-B2 | Thermally decomposable polymer compositions incorporating thermally activated base generators | PROMERUS, LLC | 2015-08-25 | — | — | US | claimed |
| US-20120318854-A1 | THERMALLY DECOMPOSABLE POLYMER COMPOSITIONS INCORPORATING THERMALLY ACTIVATED BASE GENERATORS | PROMERUS LLC (US) | 2012-12-20 | — | — | US | claimed |
| WO-2012174384-A1 | THERMALLY DECOMPOSABLE POLYMER COMPOSITIONS INCORPORATING THERMALLY ACTIVATED BASE GENERATORS | PROMERUS LLC (US) | 2012-12-20 | — | — | WO | claimed |
| US-5276211-A | Grignard reaction, cyclization, organoleptic | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1994-01-04 | — | — | US | claimed |
| EP-1469004-B1 | Method for preparing aminophosphines and aminophosphine oxides, intermediates therefor | TAKASAGO PERFUMERY CO LTD (JP) | 2006-06-14 | — | — | EP | disclosed |
| EP-1013658-B1 | Aminophosphine-metal complex for asymmetric reactions | TAKASAGO PERFUMERY CO LTD (JP) | 2004-11-03 | — | — | EP | disclosed |
| EP-1469004-A1 | Method for preparing aminophosphines and aminophosphine oxides, intermediates therefor | Takasago International Corporation (JP) | 2004-10-20 | — | — | EP | disclosed |
| US-6515156-B2 | Stereoselective, efficient catalyst for synthesis of enantiomerically pure compounds; comprising compex of transition metal and aminophosphine ligand | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2003-02-04 | — | — | US | disclosed |
| US-6388130-B2 | ALKALINE HYDROGEN PEROXIDE TO OXIDIZE 2-CYANO-2'-DIARYL PHOSPHINYL-1,1'-BINAPHTHYL TO OBTAIN A 2-AMIDO DERIVATIVE, REACTED WITH A METAL ALKOXIDE AND BROMINE IN AN ALCOHOL TO A 2-SEC-AMINO DERIVATIVE; TRANSITION METAL COMPLEX CATALYSTS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-05-14 | — | — | US | disclosed |
| US-20010047110-A1 | Method for producing axial asymmetric compounds, intermediates for producing the same, complexes of transition metals with novel axial asymmetric compounds as the ligands, catalysts for asymmetric hydrogenation, and catalysts for forming asymmetric carbon-carbon bonds | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2001-11-29 | — | — | US | disclosed |
| US-6323353-B1 | USED AS CATALYST FOR ASYMMETRIC HYDROGENATION OR CARBON-CARBON BOND | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2001-11-27 | — | — | US | disclosed |
| US-5461180-A | Contacting norbornene and aromatic hydrocarbon with solid catalyst comprising porous crystalline material | MOBIL OIL CORPORATION (US) | 1995-10-24 | — | — | US | disclosed |
| US-5281576-A | Perfumes with surfactants for detergents, fabric softener sheets | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1994-01-25 | — | — | US | disclosed |
| US-5281576-A | Perfumes with surfactants for detergents, fabric softener sheets | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1994-01-25 | — | — | US | disclosed |
| US-5281576-A | Perfumes with surfactants for detergents, fabric softener sheets | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1994-01-25 | — | — | US | disclosed |
| US-5276211-A | Grignard reaction, cyclization, organoleptic | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1994-01-04 | — | — | US | disclosed |
| US-5276211-A | Grignard reaction, cyclization, organoleptic | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1994-01-04 | — | — | US | disclosed |
| US-5276211-A | Grignard reaction, cyclization, organoleptic | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1994-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010047110-A1 | Method for producing axial asymmetric compounds, intermediates for producing the same, complexes of transition metals with novel axial asymmetric compounds as the ligands, catalysts for asymmetric hydrogenation, and catalysts for forming asymmetric carbon-carbon bonds | CORO1C, AP3M1, ARL1 | GRIN2D 809/4885GRIN3B 463/4885GRIN1 133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.